Ceftriaxone intradermal test-related fatal anaphylactic shock: a medico-legal nightmare.
Riezzo
I
I
Department of Forensic Pathology, University of Foggia, Ospedale Colonnello D'Avanzo, Foggia, Italy.
Bello
S
S
Neri
M
M
Turillazzi
E
E
Fineschi
V
V
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000322:Adrenergic Agonists / Q000627:therapeutic use; D000707:Anaphylaxis / Q000139:chemically induced* / Q000209:etiology / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001285:Atropine / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004837:Epinephrine / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007442:Intubation, Intratracheal; D008297:Male; D008318:Malpractice; D008875:Middle Aged; D009104:Multiple Trauma / Q000150:complications; D009765:Obesity / Q000150:complications; D012882:Skin Tests / Q000009:adverse effects*
D000305:Adrenal Cortex Hormones; D000322:Adrenergic Agonists; D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D002443:Ceftriaxone; D001285:Atropine; D004837:Epinephrine